UK markets closed

B.R.A.I.N. Biotechnology Research and Information Network AG (BNN.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
10.10-0.50 (-4.72%)
As of 5:53PM CEST. Market open.
Full screen
Previous close10.60
Open10.70
Bid10.10 x 100000
Ask10.35 x 100000
Day's range10.10 - 10.70
52-week range6.72 - 10.95
Volume490
Avg. volume331
Market cap183.232M
Beta (5Y monthly)1.54
PE ratio (TTM)N/A
EPS (TTM)-0.32
Earnings date29 Aug 2019 - 02 Sept 2019
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est20.35
  • EQS Group

    BRAIN Biotech AG: Sartorius and BRAIN jointly researching and adapting novel CRISPR Cas-nucleases

    DGAP-News: BRAIN Biotech AG / Key word(s): Miscellaneous28.07.2021 / 08:30 The issuer is solely responsible for the content of this announcement.Goettingen / Zwingenberg (Germany), July 28, 2021Sartorius and BRAIN jointly researching and adapting novel CRISPR Cas-nucleasesThe life science group Sartorius and BRAIN Biotech AG are jointly researching and adapting novel CRISPR-Cas genome editing nucleases for specific applications in the field of life sciences. Genome editing enables the targeted a

  • EQS Group

    BRAIN Biotech AG: Novel Genome Editing Tool: Filing of International Patent Application

    DGAP-News: BRAIN Biotech AG / Key word(s): Patent21.07.2021 / 07:30 The issuer is solely responsible for the content of this announcement.Zwingenberg (Germany), July 21st, 2021Novel Genome Editing Tool: Filing of International Patent Application Positive data evaluation Management sees strong IP position Seeking international patent protection (PCT) Positive data evaluation from recently conducted experiments has increased confidence of BRAIN Biotech AG's management in the valuable IP position o

  • EQS Group

    BRAIN Biotech AG: Additional CRISPR Genome Editing Nucleases Identified

    DGAP-News: BRAIN Biotech AG / Key word(s): Miscellaneous15.07.2021 / 11:00 The issuer is solely responsible for the content of this announcement.Zwingenberg (Germany), July 15th, 2021Additional CRISPR Genome Editing Nucleases Identified Around 2,000 Class 2 CRISPR Nucleases identified Selective additional IP protection filed Partnering discussions started BRAIN Biotech AG has identified around 2,000 so far untapped additional Class 2 CRISPR Nucleases using metagenomics sequencing which could be